Zobrazeno 1 - 10
of 671
pro vyhledávání: '"Kyrtsonis, M C"'
Autor:
Kotsianidis, I., Hatzimichael, E., Pappa, V., Galanopoulos, A., Kourakli, A., Diamantopoulos, P., Papageorgiou, S., Liapis, K., Papadopoulos, V., Papoutselis, M., Bouchla, A., Georgoulis, V., Vassilakopoulos, T., Solomou, E., Dimou, M., Vassilopoulos, G., Vardi, A., Papaioannou, M., Pontikoglou, C., Anagnostopoulos, A., Panayiotidis, P., Kontopidou, F., Harchalakis, N., Adamopoulos, N., Ximeri, M., Zikos, P., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dryllis, G., Tsoukanas, D., Kyrtsonis, M.-C., Poulakidas, E., Bouronikou, E., Delimpasis, S., Mparmparousi, D., Papadaki, H., Vyniou, N.A., Symeonidis, A.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Spiliopoulou, V., Ntanasis-Stathopoulos, I., Kyrtsonis, M-C., Symeonidis, A., Hatjiharissi, E., Giannakoulas, N., Spanoudakis, E.G., Delimpasi, S., Michali, E., Michael, M.D., Vassou, A., Iskas, M., Pouli, A., Vervessou, E., Christoulas, D., Katodritou, E., Terpos, E., Kastritis, E., Dimopoulos, M.A.C., Gavriatopoulou, M.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S604-S604
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
The “POWERFUL” multicenter, retrospective, and prospective study investigated the effectiveness of pomalidomide plus low‐dose dexamethasone (POM/LoDex) therapy in relapsed/re-fractory multiple myeloma in routine care in Greece. Ninety‐nine el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::adf4ff290474e4063d4196c8a11537b0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102545
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102545
Carfilzomib with dexamethasone (Kd) is a well-established regimen for the treatment of relapsed/refractory multiple myeloma (RRMM). There is limited information for the effects of Kd on myeloma-related bone disease. This non-interventional study aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3a8861739156f8e5a5486b1809669662
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076529
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076529
End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3bb976ff80b447b9a8f16d9cd7908710
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fe73a15e7db58341a50f122221c530c5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
Background: In a phase 1b study, intravenous daratumumab plus pomalidomide and dexamethasone induced a very good partial response or better rate of 42% and was well tolerated in patients with heavily pretreated multiple myeloma. We aimed to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b5192778089803a9faef5e873a2db795
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119602
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119602